Percutaneous Intramyocardial Septal Radiofrequency Ablation (Liwen Procedure) for Hypertrophic Cardiomyopathy: A Decade of Evolution, Clinical Experience and Future Perspectives
Advanced Ultrasound in Diagnosis and Therapy · 2026-12 · 10 (4) · 385-393
DOI: 10.26599/audt.2026.260038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Ultrasound in Diagnosis and Therapy, online erschienen am 29.10.2026. Verfasst von Liwen Liu und 4 weiteren Autor:innen. Die Arbeit nennt 58 Literaturangaben.
Abstract (Originalsprache)
Hypertrophic cardiomyopathy (HCM) is an inherited cardiomyopathy. For patients with obstructive hypertrophic cardiomyopathy (oHCM) who remain symptomatic despite medical therapy, septal reduction therapy can be performed. Surgical septal myectomy and alcohol septal ablation are the treatments for relieving left ventricular outflow tract obstruction and can effectively improve patients’ quality of life. In recent years, percutaneous intramyocardial septal radiofrequency ablation (PIMSRA/Liwen procedure) has emerged as a novel treatment for oHCM. This review traces its ten-year development from animal experiments to clinical application, covering technical principles, safety, and efficacy. Additional potentially extended applications are being explored, including non-obstructive HCM and other coexisting cardiac conditions. Future directions include longer-term follow-up, and multicenter collaboration to validate efficacy and safety in HCM patients. This review summarizes the current knowledge on PIMSRA/Liwen procedure and raises several issues that deserve further investigation.
Zitieren
APA
Liu, L., Li, J., Dang, S., Hsi, D. H., & Ta, S. (2026). Percutaneous Intramyocardial Septal Radiofrequency Ablation (Liwen Procedure) for Hypertrophic Cardiomyopathy: A Decade of Evolution, Clinical Experience and Future Perspectives. Advanced Ultrasound in Diagnosis and Therapy, 10(4), 385-393. https://doi.org/10.26599/audt.2026.260038
Vancouver
Liu L, Li J, Dang S, Hsi DH, Ta S. Percutaneous Intramyocardial Septal Radiofrequency Ablation (Liwen Procedure) for Hypertrophic Cardiomyopathy: A Decade of Evolution, Clinical Experience and Future Perspectives. Advanced Ultrasound in Diagnosis and Therapy. 2026;10(4):385-393. doi:10.26599/audt.2026.260038
BibTeX
@article{Liu2026,
author = {Liu, Liwen and Li, Jing and Dang, Shaonan and Hsi, David H. and Ta, Shengjun},
title = {Percutaneous Intramyocardial Septal Radiofrequency Ablation (Liwen Procedure) for Hypertrophic Cardiomyopathy: A Decade of Evolution, Clinical Experience and Future Perspectives},
journal = {Advanced Ultrasound in Diagnosis and Therapy},
year = {2026},
volume = {10},
number = {4},
pages = {385--393},
doi = {10.26599/audt.2026.260038}
}
EUVIMED